Juewan Kim

Juewan Kim

Auto-generated profile, based on publicly available information

Juewan Kim

Discipline of Medicine, School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2019 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
XLXiao Liu
Xiao Liu
SCSarah‐Sophia D. Carter
Sarah‐Sophia D. Carter
MRMax Jurie Renes
Max Jurie Renes
JKJuewan Kim
Juewan Kim
DRDarling Macarena Rojas‐Canales
Darling Macarena Rojas‐Canales
GWGordon G. Wallace
Gordon G. Wallace

6 July 2018 in ACS Nano
Verified
Journal Article
Closed access
SSSebastian O. Sterling
Sebastian O. Sterling
SKSvjetlana Kireta
Svjetlana Kireta
SMSteven McInnes
Steven McInnes
FKFrancis D. Kette
Francis D. Kette
KSKisha N. Sivanathan
Kisha N. Sivanathan
PCPatrick T. Coates
Patrick T. Coates

20 February 2020 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
JKJuewan Kim
Juewan Kim
CHChristopher M. Hope
Christopher M. Hope
NGNarangerel Gantumur
Narangerel Gantumur
GPGriffith B. Perkins
Griffith B. Perkins
SSSebastian O. Stead
Sebastian O. Stead
PCPatrick Toby Coates
Patrick Toby Coates

4 July 2019 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
JKJuewan Kim
Juewan Kim
KKKyungwon Kang
Kyungwon Kang
CDChristopher J. Drogemuller
Christopher J. Drogemuller
GWGordon G. Wallace
Gordon G. Wallace
PCP. Toby Coates
P. Toby Coates

1 January 2020 in Clinical & Translational Immunology
Verified
Journal Article
Open access
PDF file
JKJuewan Kim
Juewan Kim
CHChristopher M Hope
Christopher M Hope
GPGriffith B Perkins
Griffith B Perkins
SSSebastian O Stead
Sebastian O Stead
JSJacqueline C Scaffidi
Jacqueline C Scaffidi
PCPatrick Toby Coates
Patrick Toby Coates
Objectives: Regulatory T cells (Tregs) are a vital sub‐population of CD4+ T cells with major roles in immune tolerance and homeostasis. Given such properties, the use of regulatory T cells for immunotherapies has been extensively investigated, with a focus on adoptive transfer of ex vivo expanded natural Tregs (nTregs). For immunotherapies, induced Tregs (iTregs), generated in vitro from naïve CD4+ T cells, provide an attractive alternative, given the ease of generating cell numbers required for clinical dosage. While the combination of TGF‐β, ATRA and rapamycin has been shown to generate highly suppressive iTregs, the challenge for therapeutic iTreg generation has been their instability. Here, we investigate the impact of rapamycin concentrations and α‐CD3/CD28 bead ratios on human iTreg stability.Methods: We assess iTregs generated with various concentrations of rapamycin and differing ratios of α‐CD3/CD28 beads for their differentiation, stability, expression of Treg signature molecules and T helper effector cytokines, and Treg‐specific demethylation region (TSDR) status.Results: iTregs generated in the presence of TGF‐β, ATRA, rapamycin and a higher ratio of α‐CD3/CD28 beads were highly suppressive and stable upon in vitro re‐stimulation. These iTregs exhibited a similar expression profile of Treg signature molecules and T helper effector cytokines to nTregs, in the absence of TSDR demethylation.Conclusion: This work establishes a method to generate human iTregs which maintain stable phenotype and function upon in vitro re‐stimulation. Further validation in pre‐clinical models will be needed to ensure its suitability for applications in adoptive transfer.

1 April 2021 in Kidney International
Verified
Journal Article
Closed access
GPGriffith Perkins
Griffith Perkins
JKJuewan Kim
Juewan Kim
PCP. Toby Coates
P. Toby Coates